Valuation: Becton, Dickinson and Company

Market Cap 4.82TCr 4.28TCr 3.99TCr 3.64TCr 6.87TCr 4,63000Cr 6.93TCr 48TCr 19TCr 2,36700Cr 18TCr 18TCr 7,59600Cr P/E 2026 *
34.1x
P/E 2027 * 19x
Enterprise Value 6.4TCr 5.69TCr 5.31TCr 4.84TCr 9.13TCr 6,15700Cr 9.21TCr 64TCr 25TCr 3,14700Cr 24TCr 24TCr 10,10100Cr EV / Sales 2026 *
3.32x
EV / Sales 2027 * 3.15x
Free-Float
73.18%
Yield 2026 *
2.22%
Yield 2027 * 2.26%
1 day-1.44%
1 week-2.11%
Current month-0.55%
1 month-5.51%
3 months+14.22%
6 months+14.94%
Current year-8.44%
1 week 176.22
Extreme 176.22
187.5
1 month 174.85
Extreme 174.85
188.55
Current year 139.58
Extreme 139.58
212.51
1 year 139.58
Extreme 139.58
212.51
3 years 139.58
Extreme 139.58
269.21
5 years 139.58
Extreme 139.58
286.33
10 years 139.58
Extreme 139.58
286.33
Manager TitleAgeSince
Chief Executive Officer 53 28/01/2020
Director of Finance/CFO 44 05/12/2025
Chief Tech/Sci/R&D Officer 56 04/12/2023
Director TitleAgeSince
Director/Board Member 75 24/09/2002
Director/Board Member 71 26/07/2010
Chairman 53 28/04/2021
Change 5-day change 1-year change 3-year change Capi.($)
-1.44%-2.11% - - 4.82TCr
+0.84%-3.74%-26.69%+1.85% 17TCr
-0.07%-2.55%-9.53%+11.07% 11TCr
+0.90%+1.13%-24.83%+0.58% 11TCr
-1.24%-0.76%-49.04%-12.75% 7.39TCr
-0.24%+0.69%+0.16%+72.58% 5.9TCr
-0.86%+2.96%+13.57%+59.50% 5.13TCr
-0.71%-3.82%-7.72%-31.41% 4.82TCr
+0.12%-0.17%-18.21%+20.29% 4.08TCr
-1.01%-1.45%+28.48%-9.72% 3.22TCr
Average -0.37%-0.86%-10.42%+12.44% 7.67TCr
Weighted average by Cap. -0.07%-1.30%-16.36%+10.13%

Financials

2026 *2027 *
Net sales 1.93TCr 1.71TCr 1.6TCr 1.46TCr 2.75TCr 1,85300Cr 2.77TCr 19TCr 7.5TCr 95TCr 7.24TCr 7.08TCr 3,04000Cr 1.97TCr 1.75TCr 1.64TCr 1.49TCr 2.81TCr 1,89700Cr 2.84TCr 20TCr 7.67TCr 97TCr 7.41TCr 7.25TCr 3,11200Cr
Net income 143.66Cr 127.64Cr 119.14Cr 108.59Cr 204.8Cr 14TCr 206.7Cr 1.44TCr 558.68Cr 7.06TCr 539.38Cr 527.67Cr 23TCr 233.95Cr 207.86Cr 194.01Cr 176.83Cr 333.5Cr 22TCr 336.61Cr 2.35TCr 909.79Cr 11TCr 878.37Cr 859.3Cr 37TCr
Net Debt 1.59TCr 1.41TCr 1.32TCr 1.2TCr 2.26TCr 1,52700Cr 2.29TCr 16TCr 6.18TCr 78TCr 5.96TCr 5.83TCr 2,50500Cr 1.4TCr 1.24TCr 1.16TCr 1.05TCr 1.99TCr 1,34100Cr 2.01TCr 14TCr 5.43TCr 69TCr 5.24TCr 5.12TCr 2,20000Cr
Logo Becton, Dickinson and Company
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical management systems (52.4%): medication delivery systems, pharmaceutical systems, advanced patient monitoring systems, etc.; - interventional medical equipment (23.9%): surgical instruments, urological care products, etc.; - diagnostic materials and clinical research and development tools (23.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, tools for studying genes and culturing cells, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (58.6%), Europe/Middle East/Africa (21.6%), Asia (14.2%) and other (5.6%).
Employees
72,000
Date Price Change Volume
02/26/02 $176.47 -0.55% 263
01/26/01 $177.45 -1.47% 654
30/26/30 $180.10 -0.88% 89
29/26/29 $181.69 -0.98% 100
28/26/28 $183.48 +0.27% 866
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
176.80USD
Average target price
195.67USD
Spread / Average Target
+10.67%

Quarterly revenue - Rate of surprise